Why Shandong Dongyue Organosilicon Materials' (SZSE:300821) Earnings Are Weaker Than They Seem

Despite posting strong earnings, Shandong Dongyue Organosilicon Materials Co., Ltd.'s (SZSE:300821) stock didn't move much over the last week. We think that investors might be worried about the foundations the earnings are built on.

See our latest analysis for Shandong Dongyue Organosilicon Materials

The Impact Of Unusual Items On Profit

For anyone who wants to understand Shandong Dongyue Organosilicon Materials' profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥11m worth of unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And that's as you'd expect, given these boosts are described as 'unusual'. We can see that Shandong Dongyue Organosilicon Materials' positive unusual items were quite significant relative to its profit in the year to September 2024. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Shandong Dongyue Organosilicon Materials.

An Unusual Tax Situation

Having already discussed the impact of the unusual items, we should also note that Shandong Dongyue Organosilicon Materials received a tax benefit of CN¥33m. This is of course a bit out of the ordinary, given it is more common for companies to be paying tax than receiving tax benefits! Of course, prima facie it's great to receive a tax benefit. And since it previously lost money, it may well simply indicate the realisation of past tax losses. However, the devil in the detail is that these kind of benefits only impact in the year they are booked, and are often one-off in nature. In the likely event the tax benefit is not repeated, we'd expect to see its statutory profit levels drop, at least in the absence of strong growth.

Our Take On Shandong Dongyue Organosilicon Materials' Profit Performance

In its last report Shandong Dongyue Organosilicon Materials received a tax benefit which might make its profit look better than it really is on a underlying level. Furthermore, it also benefitted from a positive unusual item, which boosted the profit result even higher. For the reasons mentioned above, we think that a perfunctory glance at Shandong Dongyue Organosilicon Materials' statutory profits might make it look better than it really is on an underlying level. If you'd like to know more about Shandong Dongyue Organosilicon Materials as a business, it's important to be aware of any risks it's facing. For example - Shandong Dongyue Organosilicon Materials has 1 warning sign we think you should be aware of.

Our examination of Shandong Dongyue Organosilicon Materials has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.